Versant Capital Management’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $72.8K | Buy |
720
+129
| +22% | +$13.4K | 0.01% | 1105 |
|
|
2026
Q1 | $57.2K | Sell |
591
-1,149
| -66% | -$118K | 0.01% | 1149 |
|
|
2025
Q4 | $185K | Sell |
1,740
-26
| -1% | -$3.01K | 0.02% | 521 |
|
|
2025
Q3 | $224K | Buy |
1,766
+29
| +2% | +$3.45K | 0.03% | 429 |
|
|
2025
Q2 | $213K | Hold |
1,737
| – | – | 0.03% | 425 |
|
|
2025
Q1 | $176K | Buy |
1,737
+1,383
| +391% | +$135K | 0.03% | 458 |
|
|
2024
Q4 | $32.7K | Buy |
354
+98
| +38% | +$9.62K | 0.01% | 762 |
|
|
2024
Q3 | $24.7K | Buy |
256
+4
| +2% | +$359 | 0.01% | 733 |
|
|
2024
Q2 | $21.6K | Buy |
252
+229
| +996% | +$19.2K | 0.01% | 684 |
|
|
2024
Q1 | $1.9K | Hold |
23
| – | – | ﹤0.01% | 1369 |
|
|
2023
Q4 | $1.53K | Hold |
23
| – | – | ﹤0.01% | 1383 |
|
|
2023
Q3 | $1.54K | Hold |
23
| – | – | ﹤0.01% | 1393 |
|
|
2023
Q2 | $1.56K | Sell |
23
-26
| -53% | -$1.63K | ﹤0.01% | 1460 |
|
|
2023
Q1 | $2.65K | Buy |
49
+43
| +717% | +$2.5K | ﹤0.01% | 1189 |
|
|
2022
Q4 | $359 | Hold |
6
| – | – | ﹤0.01% | 1485 |
|
|
2022
Q3 | $0 | Sell |
6
-2
| -25% | -$100 | ﹤0.01% | 1478 |
|
|
2022
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 1486 |
|
|
2022
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 1499 |
|
|
2021
Q4 | $0 | Sell |
8
-7
| -47% | -$361 | ﹤0.01% | 1474 |
|
|
2021
Q3 | $1K | Hold |
15
| – | – | ﹤0.01% | 1253 |
|
|
2021
Q2 | $1K | Sell |
15
-5
| -25% | -$333 | ﹤0.01% | 1262 |
|
|
2021
Q1 | $1K | Sell |
20
-39
| -66% | -$2.54K | ﹤0.01% | 1343 |
|
|
2020
Q4 | $3K | Hold |
59
| – | – | ﹤0.01% | 1039 |
|
|
2020
Q3 | $3K | Hold |
59
| – | – | ﹤0.01% | 971 |
|
|
2020
Q2 | $2K | Hold |
59
| – | – | ﹤0.01% | 1048 |
|
|
2020
Q1 | $3K | Hold |
59
| – | – | ﹤0.01% | 907 |
|
|
2019
Q4 | $3K | Sell |
59
-23
| -28% | -$1.25K | ﹤0.01% | 1056 |
|
|
2019
Q3 | $4K | Sell |
82
-3
| -4% | -$151 | ﹤0.01% | 1005 |
|
|
2019
Q2 | $4K | Hold |
85
| – | – | ﹤0.01% | 1013 |
|
|
2019
Q1 | $3K | Buy |
85
+3
| +4% | +$152 | ﹤0.01% | 1244 |
|
|
2018
Q4 | $4K | Hold |
82
| – | – | ﹤0.01% | 1084 |
|
|
2018
Q3 | $5K | Sell |
82
-7
| -8% | -$426 | ﹤0.01% | 1081 |
|
|
2018
Q2 | $4K | Hold |
89
| – | – | ﹤0.01% | 1132 |
|
|
2018
Q1 | $4K | Hold |
89
| – | – | ﹤0.01% | 1119 |
|
|
2017
Q4 | $3K | Sell |
89
-19
| -18% | -$723 | ﹤0.01% | 1238 |
|
|
2017
Q3 | $3K | Buy |
108
+24
| +29% | +$855 | ﹤0.01% | 1156 |
|
|
2017
Q2 | $3K | Hold |
84
| – | – | ﹤0.01% | 1158 |
|
|
2017
Q1 | $2K | Sell |
84
-33
| -28% | -$1.08K | ﹤0.01% | 1220 |
|
|
2016
Q4 | $3K | Buy |
117
+54
| +86% | +$1.75K | ﹤0.01% | 1117 |
|
|
2016
Q3 | $2K | Hold |
63
| – | – | ﹤0.01% | 1171 |
|
|
2016
Q2 | $1K | Sell |
63
-7
| -10% | -$219 | ﹤0.01% | 1235 |
|
|
2016
Q1 | $2K | Buy |
70
+57
| +438% | +$1.57K | ﹤0.01% | 1120 |
|
|
2015
Q4 | $0 | Buy |
+13
| New | +$370 | ﹤0.01% | 1361 |
|
Other funds holding EHC
RP
CAM
FWIA
YIH
BG
YCM
LSERS
COPPSERS
SOADOR
Versant Capital Management's EHC Position: Q2 2026 in Review
Versant Capital Management increased its Encompass Health (EHC) stake by 22% in Q2 2026, buying an estimated $13.4K and bringing the position to 720 shares worth $72.8K. The position accounts for 0.01% of the portfolio, ranked #1105.
Versant Capital Management first reported a position in EHC in Q4 2015 and has held it in 43 quarters since. The position peaked at $224K in Q3 2025. 72 funds tracked by Wall St. Rank hold EHC as of Q2 2026.
- Versant Capital Management held 720 shares of Encompass Health worth $72.8K as of Q2 2026.
- Versant Capital Management bought 129 Encompass Health shares in Q2 2026, an estimated $13.4K.
- Encompass Health made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #1105 holding.
- Versant Capital Management first reported a position in Encompass Health in Q4 2015 and has held it in 43 quarters since.
- Versant Capital Management's Encompass Health position peaked at $224K in Q3 2025.
- 72 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.